{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:20:48Z","timestamp":1770492048160,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,6]]},"DOI":"10.7759\/cureus.21961","type":"journal-article","created":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T22:29:45Z","timestamp":1644186585000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical and Molecular Profile of Patients With Condyloma Acuminatum Treated in the Brazilian Public Healthcare System"],"prefix":"10.7759","author":[{"given":"Fernando Nestor","family":"Facio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Fernanda","family":"Warick Facio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Clara","family":"Nagle Spessoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moacir","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hariel","family":"Tessaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Zanatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilia","family":"Calmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Rahal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds Cesar","family":"Fava Spessoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Condiloma genital em homens e soro positividade para HIV","volume":"12","author":"Tavares RR","year":"2000","unstructured":"Tavares RR, Passos MRL, Cavalcanti SMB, Pinheiro VMS, Rubinstein I. Condiloma genital em homens e soro positividade para HIV. DST. J Bras Doen\u00e7as Sex Trans. 2000, 12:4-27.","journal-title":"DST. J Bras Doen\u00e7as Sex Trans"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.083","article-title":"The biology and life-cycle of human papillomaviruses","volume":"30","author":"Doorbar J","year":"2012","unstructured":"Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, Stanley MA. The biology and life-cycle of human papillomaviruses. Vaccine. 2012, 30:F55-70. 10.1016\/j.vaccine.2012.06.083","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman M","year":"2016","unstructured":"Schiffman M, Doorbar J, Wentzensen N, et al.. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016, 2:16086. 10.1038\/nrdp.2016.86","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053260","article-title":"Overexpression of ANXA1 in penile carcinomas positive for high-risk HPVs","volume":"8","author":"Calmon MF","year":"2013","unstructured":"Calmon MF, Mota MT, Babeto \u00c9, et al.. Overexpression of ANXA1 in penile carcinomas positive for high-risk HPVs. PLoS One. 2013, 8:e53260. 10.1371\/journal.pone.0053260","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100746","article-title":"Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions","volume":"9","author":"Freitas LB","year":"2014","unstructured":"Freitas LB, Chen Z, Muqui EF, Boldrini NA, Miranda AE, Spano LC, Burk RD. Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions. PLoS One. 2014, 9:e100746. 10.1371\/journal.pone.0100746","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119755","article-title":"Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology","volume":"10","author":"Agorastos T","year":"2015","unstructured":"Agorastos T, Chatzistamatiou K, Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T, Constantinidis TC. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology. PLoS One. 2015, 10:e0119755. 10.1371\/journal.pone.0119755","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.12.007","article-title":"Role of human papillomavirus in penile carcinomas worldwide","volume":"69","author":"Alemany L","year":"2016","unstructured":"Alemany L, Cubilla A, Halec G, et al.. Role of human papillomavirus in penile carcinomas worldwide. Eur Urol. 2016, 69:953-61. 10.1016\/j.eururo.2015.12.007","journal-title":"Eur Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman D","year":"2012","unstructured":"Forman D, de Martel C, Lacey CJ, et al.. Global burden of human papillomavirus and related diseases. Vaccine. 2012, 30:F12-23. 10.1016\/j.vaccine.2012.07.055","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.05.032","article-title":"Genital human papillomavirus infection progression to external genital lesions: the HIM Study","volume":"69","author":"Sudenga SL","year":"2016","unstructured":"Sudenga SL, Ingles DJ, Pierce Campbell CM, et al.. Genital human papillomavirus infection progression to external genital lesions: the HIM Study. Eur Urol. 2016, 69:166-73. 10.1016\/j.eururo.2015.05.032","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir851","article-title":"Risk factors for incident condyloma in a multinational cohort of men: the HIM study","volume":"205","author":"Anic GM","year":"2012","unstructured":"Anic GM, Lee JH, Villa LL, et al.. Risk factors for incident condyloma in a multinational cohort of men: the HIM study. J Infect Dis. 2012, 205:789-93. 10.1093\/infdis\/jir851","journal-title":"J Infect Dis"},{"key":"ref11","article-title":"Biological Agents. Volume 100 B. A Review of Human Carcinogens","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological Agents. Volume 100 B. A Review of Human Carcinogens. IARC Monogr Eval Carcinog Risks Hum (ed): 2012, 100; 1-441."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu077","article-title":"Incidence, clearance, and disease progression of genital human papillomavirus infection in heterosexual men","volume":"210","author":"Moreira ED Jr","year":"2014","unstructured":"Moreira ED Jr, Giuliano AR, Palefsky J, et al.. Incidence, clearance, and disease progression of genital human papillomavirus infection in heterosexual men. J Infect Dis. 2014, 210:192-9. 10.1093\/infdis\/jiu077","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study","volume":"377","author":"Giuliano AR","year":"2011","unstructured":"Giuliano AR, Lee JH, Fulp W, et al.. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet. 2011, 377:932-40. 10.1016\/S0140-6736(10)62342-2","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2005.10.001","article-title":"Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India","volume":"166","author":"Sobti RC","year":"2006","unstructured":"Sobti RC, Kaur S, Kaur P, Singh J, Gupta I, Jain V, Nakahara A. Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India. Cancer Genet Cytogenet. 2006, 166:117-23. 10.1016\/j.cancergencyto.2005.10.001","journal-title":"Cancer Genet Cytogenet"},{"key":"ref15","article-title":"Use of polymerase chain reaction amplification for the detection of human papillomaviruses","volume":"7","author":"Manos MM","year":"1989","unstructured":"Manos MM, Ting Y, Wright DK, et al.. Use of polymerase chain reaction amplification for the detection of human papillomaviruses. Cancer cells. 1989, 7:209-14.","journal-title":"Cancer cells"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-71-1-173","article-title":"The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes","volume":"71","author":"Snijders PJ","year":"1990","unstructured":"Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol. 1990, 71:173-81. 10.1099\/0022-1317-71-1-173","journal-title":"J Gen Virol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger F","year":"1977","unstructured":"Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977, 74:5463-7. 10.1073\/pnas.74.12.5463","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6890-9-3","article-title":"Validation of human papillomavirus genotyping by signature DNA sequence analysis","volume":"9","author":"Lee SH","year":"2009","unstructured":"Lee SH, Vigliotti VS, Vigliotti JS, Pappu S. Validation of human papillomavirus genotyping by signature DNA sequence analysis. BMC Clin Pathol. 2009, 9:3. 10.1186\/1472-6890-9-3","journal-title":"BMC Clin Pathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2014.02.16","article-title":"Human papillomavirus infection is not related with prostatitis-related symptoms: results from a case-control study","volume":"40","author":"Bartoletti R","year":"2014","unstructured":"Bartoletti R, Cai T, Meliani E, et al.. Human papillomavirus infection is not related with prostatitis-related symptoms: results from a case-control study. Int Braz J Urol. 2014, 40:247-56. 10.1590\/S1677-5538.IBJU.2014.02.16","journal-title":"Int Braz J Urol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.23736\/S0393-2249.18.03141-7","article-title":"Human papilloma virus and genitourinary cancers: a narrative review","volume":"70","author":"Cai T","year":"2018","unstructured":"Cai T, Di Vico T, Durante J, Tognarelli A, Bartoletti R. Human papilloma virus and genitourinary cancers: a narrative review. Minerva Urol Nefrol. 2018, 70:579-87. 10.23736\/S0393-2249.18.03141-7","journal-title":"Minerva Urol Nefrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.04.035","article-title":"Genital condylomata are not the human papilloma virus male infection burden","volume":"60","author":"Bartoletti R","year":"2011","unstructured":"Bartoletti R, Zizzo G, Cai T, Mirone V. Genital condylomata are not the human papilloma virus male infection burden. Eur Urol. 2011, 60:268-9. 10.1016\/j.eururo.2011.04.035","journal-title":"Eur Urol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2562-z","article-title":"Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes","volume":"35","author":"Cai T","year":"2016","unstructured":"Cai T, Perletti G, Meacci F, et al.. Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes. Eur J Clin Microbiol Infect Dis. 2016, 35:463-9. 10.1007\/s10096-015-2562-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4067\/S0716-10182013000200009","article-title":"[Detection of human papilloma virus infection in men]","volume":"30","author":"Silva R","year":"2013","unstructured":"Silva R, Le\u00f3n D, Brebi P, Ili C, Roa JC, S\u00e1nchez R. [Detection of human papilloma virus infection in men]. Rev Chilena Infectol. 2013, 30:186-92. 10.4067\/S0716-10182013000200009","journal-title":"Rev Chilena Infectol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/85394-clinical-and-molecular-profile-of-patients-with-condyloma-acuminatum-treated-in-the-brazilian-public-healthcare-system","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:41Z","timestamp":1707507881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/85394-clinical-and-molecular-profile-of-patients-with-condyloma-acuminatum-treated-in-the-brazilian-public-healthcare-system"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,6]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.21961","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,6]]}}}